BioLife Solutions Inc (BLFS)
NASDAQ
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-04-08 | Dr. Aby J. MathewChairman of Scientific Advisory Board, Exec. VP & Chief Scientific Officer | -515.00 | 9.92k | Sale to Issuer | 19.27 | 390.17k | -0.13% |
| 2026-04-08 | Mr. Todd BerardChief Commercial Officer | -293.00 | 5.65k | Sale to Issuer | 19.27 | 163.77k | -0.18% |
| 2026-04-08 | Mr. Troy WichtermanCFO | -844.00 | 16.26k | Sale to Issuer | 19.27 | 216.06k | -0.39% |
| 2026-03-23 | Ms. Karen Fosterインサイダー | -2.58k | 49.40k | Automatic Disposition | 19.17 | 108.76k | -2.31% |
| 2026-03-19 | Mr. Roderick de GreefCEO & Chairman | -11.10k | 212.25k | Sale to Issuer | 19.12 | 357.64k | -3.01% |
| 2026-03-19 | Ms. Karen Fosterインサイダー | -1.91k | 36.46k | Sale to Issuer | 19.12 | 111.34k | -1.68% |
| 2026-03-19 | Ms. Sarah Aebersoldインサイダー | -931.00 | 17.80k | Sale to Issuer | 19.12 | 92.43k | -1.00% |
| 2026-03-19 | Mr. Sean WernerCTO | -1.68k | 32.14k | Sale to Issuer | 19.12 | 48.25k | -3.37% |
| 2026-03-19 | Mr. Troy WichtermanCFO | -3.75k | 71.68k | Sale to Issuer | 19.12 | 216.90k | -1.70% |
| 2026-03-19 | Mr. Todd BerardChief Commercial Officer | -1.88k | 35.93k | Sale to Issuer | 19.12 | 164.06k | -1.13% |
| 2026-03-19 | Dr. Aby J. MathewChairman of Scientific Advisory Board, Exec. VP & Chief Scientific Officer | -2.26k | 43.12k | Sale to Issuer | 19.12 | 390.68k | -0.57% |
| 2026-03-05 | Ms. Karen Fosterインサイダー | -97.42k | 1.96M | 売り | 20.00 - 20.15 | 113.24k | -46.25% |
| 2026-03-03 | Mr. Sean WernerCTO | -111.00 | 2.30k | Automatic Disposition | 20.74 | 49.93k | -0.22% |
| 2026-03-03 | Ms. Sarah Aebersoldインサイダー | -219.00 | 4.54k | Automatic Disposition | 20.74 | 93.36k | -0.23% |
| 2026-03-03 | Mr. Todd BerardChief Commercial Officer | -353.00 | 7.32k | Automatic Disposition | 20.74 | 165.94k | -0.21% |
| 2026-03-03 | Mr. Troy WichtermanCFO | -588.00 | 12.20k | Automatic Disposition | 20.74 | 220.65k | -0.27% |
| 2026-03-03 | Dr. Aby J. MathewChairman of Scientific Advisory Board, Exec. VP & Chief Scientific Officer | -529.00 | 10.97k | Automatic Disposition | 20.74 | 392.94k | -0.13% |
| 2026-03-03 | Ms. Karen Fosterインサイダー | -418.00 | 8.67k | Automatic Disposition | 20.74 | 210.67k | -0.20% |
| 2026-02-24 | Dr. Aby J. MathewChairman of Scientific Advisory Board, Exec. VP & Chief Scientific Officer | -15.59k | 353.00k | Sale to Issuer | 22.65 | 393.47k | -3.81% |
| 2026-02-24 | Mr. Troy WichtermanCFO | -25.53k | 578.14k | Sale to Issuer | 22.65 | 221.24k | -10.34% |
| 2026-02-24 | Mr. Todd BerardChief Commercial Officer | -8.85k | 200.36k | Sale to Issuer | 22.65 | 166.29k | -5.05% |
| 2026-02-24 | Mr. Roderick de GreefCEO & Chairman | -153.20k | 3.47M | Sale to Issuer | 22.65 | 459.26k | -25.01% |
| 2026-02-24 | Ms. Karen Fosterインサイダー | -13.01k | 294.74k | Sale to Issuer | 22.65 | 211.08k | -5.81% |
| 2026-02-24 | Ms. Sarah Aebersoldインサイダー | -5.73k | 129.88k | Sale to Issuer | 22.65 | 93.58k | -5.77% |
| 2026-01-06 | Mr. Troy WichtermanCFO | -990.00 | 25.33k | Automatic Disposition | 25.59 | 150.75k | -0.65% |
| 2026-01-06 | Mr. Todd BerardChief Commercial Officer | -344.00 | 8.80k | Automatic Disposition | 25.59 | 132.56k | -0.26% |
| 2026-01-06 | Dr. Aby J. MathewChairman of Scientific Advisory Board, Exec. VP & Chief Scientific Officer | -405.00 | 10.36k | Automatic Disposition | 25.59 | 349.35k | -0.12% |
| 2026-01-06 | Ms. Sarah Aebersoldインサイダー | -241.00 | 6.17k | Automatic Disposition | 25.59 | 75.77k | -0.32% |
| 2026-01-06 | Ms. Karen Fosterインサイダー | -335.00 | 8.57k | Automatic Disposition | 25.59 | 191.98k | -0.17% |
| 2025-12-09 | Ms. Karen Fosterインサイダー | -519.00 | 13.04k | Automatic Disposition | 25.13 | 192.32k | -0.27% |
| 2025-12-09 | Mr. Todd BerardChief Commercial Officer | -358.00 | 9.00k | Automatic Disposition | 25.13 | 132.91k | -0.27% |
| 2025-12-15 | Ms. Amy DuRossIndependent Lead Director | -2.00k | 49.20k | 売り | 24.60 | 18.69k | -9.67% |
| 2025-12-15 | Ms. Sarah Aebersoldインサイダー | -713.00 | 17.44k | 売り | 24.46 | 76.01k | -0.93% |
| 2025-12-09 | Ms. Sarah Aebersoldインサイダー | -233.00 | 5.86k | Automatic Disposition | 25.13 | 76.01k | -0.31% |
| 2025-12-09 | Mr. Troy WichtermanCFO | -1.03k | 25.96k | Automatic Disposition | 25.13 | 151.74k | -0.68% |
| 2025-12-09 | Dr. Aby J. MathewChairman of Scientific Advisory Board, Exec. VP & Chief Scientific Officer | -631.00 | 15.86k | Automatic Disposition | 25.13 | 349.76k | -0.18% |
| 2025-12-04 | Mr. Troy WichtermanCFO | -30.00k | 771.60k | 売り | 25.72 | 152.77k | -16.41% |
| 2025-11-25 | Ms. Amy DuRossIndependent Lead Director | -4.00k | 108.00k | 売り | 27.00 | 20.69k | -16.20% |
| 2025-11-25 | Mr. Todd BerardChief Commercial Officer | -351.00 | 9.39k | Automatic Disposition | 26.74 | 133.27k | -0.26% |
| 2025-11-25 | Ms. Sarah Aebersoldインサイダー | -217.00 | 5.80k | Automatic Disposition | 26.74 | 76.95k | -0.28% |
| 2025-11-25 | Mr. Troy WichtermanCFO | -584.00 | 15.62k | Automatic Disposition | 26.74 | 182.77k | -0.32% |
| 2025-11-25 | Mr. Sean WernerCTO | -110.00 | 2.94k | Automatic Disposition | 26.74 | 25.93k | -0.42% |
| 2025-11-25 | Dr. Aby J. MathewChairman of Scientific Advisory Board, Exec. VP & Chief Scientific Officer | -526.00 | 14.07k | Automatic Disposition | 26.74 | 350.39k | -0.15% |
| 2025-11-25 | Ms. Karen Fosterインサイダー | -415.00 | 11.10k | Automatic Disposition | 26.74 | 192.84k | -0.21% |
| 2025-11-19 | Ms. Amy DuRossIndependent Lead Director | -6.00k | 148.55k | 売り | 24.50 - 26.00 | 24.69k | -19.55% |
| 2025-11-11 | Mr. Roderick de GreefCEO & Chairman | -100.00k | 2.58M | 売り | 25.33 - 26.15 | 79.74k | -55.64% |
| 2025-10-24 | Dr. Joydeep GoswamiIndependent Director | -1.67k | 48.30k | Automatic Disposition | 28.99 | 44.99k | -3.57% |
| 2025-10-22 | Mr. Roderick de GreefCEO & Chairman | -37.80k | 1.03M | Automatic Disposition | 27.30 | 179.74k | -17.37% |
| 2025-10-20 | Mr. Sean WernerCTO | -275.00 | 7.65k | Automatic Disposition | 27.82 | 26.04k | -1.05% |
| 2025-10-16 | Dr. Joydeep GoswamiIndependent Director | -1.33k | 0.00 | Automatic Disposition | - | 46.65k | -2.78% |
| 2025-10-15 | Casdin Capital, LLC法人 | -750.00k | 21.41M | 売り | 28.55 | 5.96M | -11.18% |
| 2025-10-09 | Dr. Aby J. MathewChairman of Scientific Advisory Board, Exec. VP & Chief Scientific Officer | -509.00 | 13.93k | Automatic Disposition | 27.36 | 350.91k | -0.14% |
| 2025-10-09 | Mr. Todd BerardChief Commercial Officer | -289.00 | 7.91k | Automatic Disposition | 27.36 | 133.62k | -0.22% |
| 2025-10-09 | Mr. Troy WichtermanCFO | -833.00 | 22.79k | Automatic Disposition | 27.36 | 183.35k | -0.45% |
| 2025-10-09 | Ms. Karen Fosterインサイダー | -419.00 | 11.46k | Automatic Disposition | 27.36 | 193.25k | -0.22% |
| 2025-10-09 | Ms. Sarah Aebersoldインサイダー | -188.00 | 5.14k | Automatic Disposition | 27.36 | 77.17k | -0.24% |
| 2025-09-15 | Ms. Sarah Aebersoldインサイダー | -714.00 | 18.29k | Automatic Disposition | 25.61 | 77.36k | -0.91% |
| 2025-09-11 | Mr. Todd BerardChief Commercial Officer | -358.00 | 9.61k | Automatic Disposition | 26.83 | 133.91k | -0.27% |
| 2025-09-11 | Dr. Aby J. MathewChairman of Scientific Advisory Board, Exec. VP & Chief Scientific Officer | -630.00 | 16.90k | Automatic Disposition | 26.83 | 351.42k | -0.18% |
| 2025-09-11 | Ms. Karen Fosterインサイダー | -511.00 | 13.71k | Automatic Disposition | 26.83 | 193.67k | -0.26% |
| 2025-09-11 | Ms. Sarah Aebersoldインサイダー | -233.00 | 6.25k | Automatic Disposition | 26.83 | 78.07k | -0.30% |
| 2025-09-11 | Mr. Sean WernerCTO | -72.00 | 1.93k | Automatic Disposition | 26.83 | 26.31k | -0.27% |
| 2025-09-11 | Mr. Troy WichtermanCFO | -1.03k | 27.69k | Automatic Disposition | 26.83 | 184.19k | -0.56% |
| 2025-08-26 | Dr. Aby J. MathewChairman of Scientific Advisory Board, Exec. VP & Chief Scientific Officer | -531.00 | 13.51k | Automatic Disposition | 25.44 | 352.05k | -0.15% |
| 2025-08-26 | Ms. Sarah Aebersoldインサイダー | -219.00 | 5.57k | Automatic Disposition | 25.44 | 78.30k | -0.28% |
| 2025-08-26 | Mr. Troy WichtermanCFO | -590.00 | 15.01k | Automatic Disposition | 25.44 | 185.22k | -0.32% |
| 2025-08-26 | Mr. Sean WernerCTO | -111.00 | 2.82k | Automatic Disposition | 25.44 | 26.38k | -0.42% |
| 2025-08-26 | Ms. Karen Fosterインサイダー | -413.00 | 10.51k | Automatic Disposition | 25.44 | 194.18k | -0.21% |
| 2025-08-26 | Mr. Todd BerardChief Commercial Officer | -354.00 | 9.01k | Automatic Disposition | 25.44 | 134.26k | -0.26% |
| 2025-08-25 | Mr. Todd BerardChief Commercial Officer | -10.00k | 255.30k | 売り | 25.53 | 124.62k | -7.43% |
| 2025-08-15 | Casdin Capital, LLC法人 | -500.00k | 12.20M | 売り | 24.40 | 6.71M | -6.94% |
| 2025-08-11 | Casdin Capital, LLC法人 | -500.00k | 11.30M | 売り | 22.60 | 7.21M | -6.49% |
| 2025-07-18 | Mr. Sean WernerCTO | -1.12k | 23.66k | Automatic Disposition | 21.22 | 26.50k | -4.04% |
| 2025-07-07 | Ms. Karen Fosterインサイダー | -400.00 | 8.91k | Automatic Disposition | 22.27 | 194.60k | -0.21% |
| 2025-07-07 | Ms. Sarah Aebersoldインサイダー | -198.00 | 4.41k | Automatic Disposition | 22.27 | 78.52k | -0.25% |
| 2025-07-07 | Mr. Todd BerardChief Commercial Officer | -304.00 | 6.77k | Automatic Disposition | 22.27 | 134.62k | -0.23% |
| 2025-07-07 | Dr. Aby J. MathewChairman of Scientific Advisory Board, Exec. VP & Chief Scientific Officer | -536.00 | 11.94k | Automatic Disposition | 22.27 | 352.58k | -0.15% |
| 2025-07-07 | Mr. Troy WichtermanCFO | -877.00 | 19.53k | Automatic Disposition | 22.27 | 185.81k | -0.47% |
| 2025-06-16 | Ms. Sarah Aebersoldインサイダー | -711.00 | 15.81k | Automatic Disposition | 22.23 | 78.72k | -0.90% |
| 2025-06-10 | Casdin Capital, LLC法人 | -1,000.00k | 23.80M | 売り | 23.80 | 7.71M | -11.48% |
| 2025-06-10 | Mr. Todd BerardChief Commercial Officer | -362.00 | 8.58k | Automatic Disposition | 23.70 | 134.92k | -0.27% |
| 2025-06-10 | Ms. Karen Fosterインサイダー | -320.00 | 7.58k | Automatic Disposition | 23.70 | 195.00k | -0.16% |
| 2025-06-10 | Ms. Sarah Aebersoldインサイダー | -235.00 | 5.57k | Automatic Disposition | 23.70 | 79.43k | -0.29% |
| 2025-06-10 | Mr. Sean WernerCTO | -65.00 | 1.54k | Automatic Disposition | 23.70 | 27.61k | -0.23% |
| 2025-06-10 | Mr. Troy WichtermanCFO | -1.04k | 24.70k | Automatic Disposition | 23.70 | 186.69k | -0.56% |
| 2025-06-10 | Dr. Aby J. MathewChairman of Scientific Advisory Board, Exec. VP & Chief Scientific Officer | -637.00 | 15.10k | Automatic Disposition | 23.70 | 353.12k | -0.18% |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。